Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Neil Trushin is active.

Publication


Featured researches published by Neil Trushin.


Cancer Letters | 1999

Evaluation of butylated hydroxyanisole, myo-inositol, curcumin, esculetin, resveratrol and lycopene as inhibitors of benzo[a]pyrene plus 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced lung tumorigenesis in A/J mice

Stephen S. Hecht; Patrick M.J. Kenney; Mingyao Wang; Neil Trushin; Sanjiv Agarwal; A. Venket Rao; Pramod Upadhyaya

The potential activities of butylated hydroxyanisole (BHA), myo-inositol, curcumin, esculetin, resveratrol and lycopene-enriched tomato oleoresin (LTO) as chemopreventive agents against lung tumor induction in A/J mice by the tobacco smoke carcinogens benzo[a]pyrene (BaP) and 4-(methyl-nitrosamino)-1-(3-pyridyl)-1-butanone (NNK) were evaluated. Groups of 20 A/J mice were treated weekly by gavage with a mixture of BaP and NNK (3 micromol each) for 8 weeks, then sacrificed 26 weeks after the first carcinogen treatment. Mice treated with BHA (20 or 40 micromol) by gavage 2 h before each dose of BaP and NNK had significantly reduced lung tumor multiplicity. Treatment with BHA (20 or 40 micromol) by gavage weekly or with dietary BHA (2000 ppm), curcumin (2000 ppm) or resveratrol (500 ppm) from 1 week after carcinogen treatment until termination had no effect on lung tumor multiplicity. Treatment with dietary myo-inositol (30,000 ppm) or esculetin (2000 ppm) from 1 week after carcinogen treatment until termination significantly reduced lung tumor multiplicity, with the effect of myo-inositol being significantly greater than that of esculetin. Treatment with dietary LTO (167, 1667 or 8333 ppm) from 1 week before carcinogen treatment until termination had no effect on lung tumor multiplicity. The results of this study demonstrate that BHA is an effective inhibitor of BaP plus NNK-induced lung tumorigenesis in A/J mice when administered during the period of carcinogen treatment and that, among the compounds tested, myo-inositol is most effective after carcinogen treatment.


Cancer Letters | 2000

Effects of phenethyl isothiocyanate and benzyl isothiocyanate, individually and in combination, on lung tumorigenesis induced in A/J mice by benzo[a]pyrene and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.

Stephen S. Hecht; Patrick M.J. Kenney; Mingyao Wang; Neil Trushin; Pramod Upadhyaya

Phenethyl isothiocyanate (PEITC) is an effective inhibitor of lung tumorigenesis induced in rats and mice by the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) while benzyl isothiocyanate (BITC) inhibits lung tumorigenesis induced in mice by another tobacco smoke carcinogen, benzo[a]pyrene (BaP). However, little is known about the inhibitory effects of PEITC and BITC in combination, or about the effects of PEITC or BITC on tumorigenesis by a mixture of NNK and BaP. In this study, we carried out a series of experiments pertinent to these questions. In Experiment 1, treatment of A/J mice with PEITC (6 micromol), BITC (6 micromol), or a combination of the two (6 micromol each) by gavage, 2 h prior to each of eight weekly gavage treatments with a mixture of BaP and NNK (3 micromol of each), had no effect on lung tumor multiplicity. In Experiment 2, we evaluated the inhibitory potential of four different mixtures of PEITC and BITC, administered by gavage 2 h prior to each of eight weekly doses of BaP and NNK, as given in Experiment 1. Mixtures of PEITC and BITC (12 micromol of each, or 12 micromol PEITC and 9 micromol BITC) significantly reduced lung tumorigenesis induced by a mixture of BaP and NNK. In Experiment 3, we investigated the effects of dietary PEITC (3 micromol/g diet), BITC (1 micromol/g diet), or a mixture of PEITC (3 micromol/g diet) and BITC (1 micromol/g diet). These compounds were started 1 week before, and continued through to 1 week after the eight weekly treatments with BaP and NNK. PEITC, and PEITC plus BITC, both significantly inhibited lung tumor multiplicity; inhibition was due mainly to PEITC. In Experiment 4, we tested dietary PEITC (3, 1, or 0.3 micromol/g diet) as an inhibitor of lung tumorigenesis induced by BaP, NNK, or BaP plus NNK using a protocol identical to that in Experiment 3. PEITC was an effective inhibitor of lung tumor multiplicity induced by NNK and a mixture of BaP plus NNK, but not by BaP. Dietary PEITC, or PEITC plus BITC, was more effective in these experiments than the compounds given by gavage. The results of this study demonstrate that proper doses of dietary PEITC and dietary as well as gavaged PEITC plus BITC are effective inhibitors of lung tumorigenesis induced in A/J mice by a mixture of BaP and NNK.


Cancer Research | 1986

Comparative Tumorigenicity and DNA Methylation in F344 Rats by 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone and N-Nitrosodimethylamine

Stephen S. Hecht; Neil Trushin; Andre Castonguay; Abraham Rivenson


Cancer Epidemiology, Biomarkers & Prevention | 1996

Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate.

Stephen S. Hecht; Neil Trushin; Jeffrey Rigotty; Steven G. Carmella; Anna Borukhova; Shobha A. Akerkar; Abraham Rivenson


Carcinogenesis | 1993

Metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the patas monkey: pharmacokinetics and characterization of glucuronide metabolites

Stephen S. Hecht; Neil Trushin; Cheri A. Reid-Quinn; Eric S. Burak; Ann B. Jones; Janice L. Southers; Charles T. Gombar; Steven G. Carmella; Lucy M. Anderson; Jerry M. Rice


Carcinogenesis | 1988

Evidence for 4-(3-pyridyl)-4-oxobutylation of DNA in F344 rats treated with the tobacco-specific nitrosamines 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and N′-nitrosonornicotine

Stephen S. Hecht; Thomas E. Spratt; Neil Trushin


Carcinogenesis | 1994

Lung tumor induction in A/J mice by the tobacco smoke carcinogens 4-(methylnitrosamino)-l-(3-pyridyl)-l-butanone and benzo[a]pyrene: a potentially useful model for evaluation of chemopreventive agents

Stephen S. Hecht; Shelley Isaacs; Neil Trushin


Cancer Research | 1984

Effects of Chronic Ethanol Consumption on the Metabolism and Carcinogenicity of N′-Nitrosonornicotine in F344 Rats

Andre Castonguay; Abraham Rivenson; Neil Trushin; Joel Reinhardt; Stella Spathopoulos; Carol J. Weiss; Betti Reiss; Stephen S. Hecht


Cancer Research | 1990

Comparative Metabolism of N′-Nitrosonornicotine and 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone by Cultured F344 Rat Oral Tissue and Esophagus

Sharon E. Murphy; Rachel Heiblum; Neil Trushin


Carcinogenesis | 1990

Effects of deuterium substitution on the tumorigenicity of 4-(metlhylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in A/J mice

Stephen S. Hecht; Kevin G. Jordan; Chang In Choi; Neil Trushin

Collaboration


Dive into the Neil Trushin's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Andre Castonguay

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Thomas E. Spratt

Pennsylvania State University

View shared research outputs
Top Co-Authors

Avatar

Peter G. Foiles

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Anna Borukhova

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Carmella Sg

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar

Dorothy Lin

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Lucy M. Anderson

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Mingyao Wang

University of Minnesota

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge